About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

NCT02294058·224 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Celgene

Age

18–55

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Multiple sclerosis as diagnosed by the revised 2010 McDonald criteria
EDSS score between 0 and 5.0 at baseline

You may not be if

Primary progressive multiple sclerosis

The record

StatusCompleted

PhasePhase 3

Taking part1,346

StartedDec 2014

UpdatedNov 25, 2020

Conditions

Multiple Sclerosis

Where224

Xenosciences Inc
Phoenix, Arizona, United States
St Josephs Hospital and Medical Center
Phoenix, Arizona, United States
Northwest Neuro Specialists PLLC
Tucson, Arizona, United States